Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jul 9, 2026
Data as of Oct 16
▼ SELL$799K1,452 shares at $550.12Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
- Traded
- Jul 9, 2026
- Disclosed
- Jul 9, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
−3.5%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund
Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$443Kdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$910Kdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$241Kdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.6Mdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$843Kdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$355Kdisclosed Jul 9 · filed the same day
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$66.7Kdisclosed Jul 9 · filed the same day